AmacaThera, a developer of next-generation hydrogel-based drug delivery solutions, announced on Wednesday that it has been named Emerging Company of the Year by Life Sciences Ontario.

According to AmacaThera, this award highlights the company's evolution from an early-stage biotech into a global innovator, reflecting recognition from the broader life sciences community for its scientific excellence, innovative hydrogel technology, and increasing influence within the sector.

Mike Cooke, AmacaThera's CEO, said: "We are honoured to receive this recognition from Life Sciences Ontario. It reflects the strength of our scientific innovation and the growing relevance of next-generation, hydrogel-based drug delivery solutions. As we evolve from an early-stage biotech into a global innovator, I am proud of our multidisciplinary team whose expertise and dedication have been instrumental in our progress."